Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and cerebral oxygen saturation during hyperventilation in endoscopic sinus surgery
ChiCTR2400090177Phase 4Not yet recruiting
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in rhinosinusitis (2 arms), sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Primary endpoint: Changes of rSO2 after target controlled infusion of dexmedetomidine. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on ChiCTR2400090177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090177.